• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性淋巴细胞白血病中H/ACA核糖核蛋白成分的失调

Dysregulation of H/ACA ribonucleoprotein components in chronic lymphocytic leukemia.

作者信息

Dos Santos Patricia Carolina, Panero Julieta, Stanganelli Carmen, Palau Nagore Virginia, Stella Flavia, Bezares Raimundo, Slavutsky Irma

机构信息

Laboratorio de Genética de Neoplasias Linfoides, Instituto de Medicina Experimental, CONICET-Academia Nacional de Medicina, Buenos Aires, Argentina.

División Patología Molecular, Instituto de Investigaciones Hematológicas-Academia Nacional de Medicina, Buenos Aires, Argentina.

出版信息

PLoS One. 2017 Jun 30;12(6):e0179883. doi: 10.1371/journal.pone.0179883. eCollection 2017.

DOI:10.1371/journal.pone.0179883
PMID:28666010
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5493334/
Abstract

Telomeres are protective repeats of TTAGGG sequences located at the end of human chromosomes. They are essential to maintain chromosomal integrity and genome stability. Telomerase is a ribonucleoprotein complex containing an internal RNA template (hTR) and a catalytic subunit (hTERT). The human hTR gene consists of three major domains; among them the H/ACA domain is essential for telomere biogenesis. H/ACA ribonucleoprotein (RNP) complex is composed of four evolutionary conserved proteins, including dyskerin (encoded by DKC1 gene), NOP10, NHP2 and GAR1. In this study, we have evaluated the expression profile of the H/ACA RNP complex genes: DKC1, NOP10, NHP2 and GAR1, as well as hTERT and hTR mRNA levels, in patients with chronic lymphocytic leukemia (CLL). Results were correlated with the number and type of genetic alteration detected by conventional cytogenetics and FISH (fluorescence in situ hybridization), IGHV (immunoglobulin heavy chain variable region) mutational status, telomere length (TL) and clinico-pathological characteristics of patients. Our results showed significant decreased expression of GAR1, NOP10, DKC1 and hTR, as well as increased mRNA levels of hTERT in patients compared to controls (p≤0.04). A positive correlation between the expression of GAR1-NHP2, GAR1-NOP10, and NOP10-NHP2 (p<0.0001), were observed. The analysis taking into account prognostic factors showed a significant increased expression of hTERT gene in unmutated-IGHV cases compared to mutated-CLL patients (p = 0.0185). The comparisons among FISH groups exhibited increased expression of DKC1 in cases with two or more alterations with respect to no abnormalities, trisomy 12 and del13q14, and of NHP2 and NOP10 compared to those with del13q14 (p = 0.03). The analysis according to TL showed a significant increased expression of hTERT (p = 0.0074) and DKC1 (p = 0.0036) in patients with short telomeres compared to those with long TL. No association between gene expression and clinical parameters was found. Our results suggest a role for these telomere associated genes in genomic instability and telomere dysfunction in CLL.

摘要

端粒是位于人类染色体末端的TTAGGG序列的保护性重复序列。它们对于维持染色体完整性和基因组稳定性至关重要。端粒酶是一种核糖核蛋白复合体,包含一个内部RNA模板(hTR)和一个催化亚基(hTERT)。人类hTR基因由三个主要结构域组成;其中H/ACA结构域对于端粒生物合成至关重要。H/ACA核糖核蛋白(RNP)复合体由四种进化保守蛋白组成,包括戴氏蛋白(由DKC1基因编码)、NOP10、NHP2和GAR1。在本研究中,我们评估了慢性淋巴细胞白血病(CLL)患者中H/ACA RNP复合体基因(DKC1、NOP10、NHP2和GAR1)的表达谱,以及hTERT和hTR mRNA水平。结果与通过传统细胞遗传学和荧光原位杂交(FISH)检测到的基因改变的数量和类型、免疫球蛋白重链可变区(IGHV)突变状态、端粒长度(TL)以及患者的临床病理特征相关。我们的结果显示,与对照组相比,患者中GAR1、NOP10、DKC1和hTR的表达显著降低,而hTERT的mRNA水平升高(p≤0.04)。观察到GAR1与NHP2、GAR1与NOP10以及NOP10与NHP2的表达之间呈正相关(p<0.0001)。考虑预后因素的分析显示,与突变型CLL患者相比,未突变IGHV病例中hTERT基因的表达显著增加(p = 0.0185)。FISH组之间的比较显示,与无异常、三体12和del13q14相比,有两种或更多改变的病例中DKC1的表达增加,与del13q14相比,NHP2和NOP10的表达增加(p = 0.03)。根据TL进行的分析显示,与长TL患者相比,短端粒患者中hTERT(p = 0.0074)和DKC1(p = 0.0036)的表达显著增加。未发现基因表达与临床参数之间的关联。我们的结果表明这些端粒相关基因在CLL的基因组不稳定性和端粒功能障碍中发挥作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/329c/5493334/3c839a511ca6/pone.0179883.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/329c/5493334/5b897fb096b6/pone.0179883.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/329c/5493334/a7225d19b35b/pone.0179883.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/329c/5493334/48f140c784ef/pone.0179883.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/329c/5493334/3c839a511ca6/pone.0179883.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/329c/5493334/5b897fb096b6/pone.0179883.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/329c/5493334/a7225d19b35b/pone.0179883.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/329c/5493334/48f140c784ef/pone.0179883.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/329c/5493334/3c839a511ca6/pone.0179883.g004.jpg

相似文献

1
Dysregulation of H/ACA ribonucleoprotein components in chronic lymphocytic leukemia.慢性淋巴细胞白血病中H/ACA核糖核蛋白成分的失调
PLoS One. 2017 Jun 30;12(6):e0179883. doi: 10.1371/journal.pone.0179883. eCollection 2017.
2
Mutations in the telomerase component NHP2 cause the premature ageing syndrome dyskeratosis congenita.端粒酶组分NHP2的突变会导致早衰综合征先天性角化不良。
Proc Natl Acad Sci U S A. 2008 Jun 10;105(23):8073-8. doi: 10.1073/pnas.0800042105. Epub 2008 Jun 3.
3
Pseudouridylation defect due to and mutations causes nephrotic syndrome with cataracts, hearing impairment, and enterocolitis.由于 和 突变导致的假尿嘧啶化缺陷引起伴有白内障、听力障碍和肠病的肾病综合征。
Proc Natl Acad Sci U S A. 2020 Jun 30;117(26):15137-15147. doi: 10.1073/pnas.2002328117. Epub 2020 Jun 17.
4
Telomere length and expression of human telomerase reverse transcriptase splice variants in chronic lymphocytic leukemia.端粒长度和人类端粒酶逆转录酶剪接变异体在慢性淋巴细胞白血病中的表达。
Exp Hematol. 2013 Jul;41(7):615-26. doi: 10.1016/j.exphem.2013.03.008. Epub 2013 Mar 30.
5
Novel pathological variants of NHP2 affect N-terminal domain flexibility, protein stability, H/ACA Ribonucleoprotein (RNP) complex formation and telomerase activity.新型 NHP2 病理性变异影响 N 端结构域的灵活性、蛋白稳定性、H/ACA 核糖核蛋白(RNP)复合物形成和端粒酶活性。
Hum Mol Genet. 2023 Sep 16;32(19):2901-2912. doi: 10.1093/hmg/ddad114.
6
Telomere length and telomerase levels delineate subgroups of B-cell chronic lymphocytic leukemia with different biological characteristics and clinical outcomes.端粒长度和端粒酶水平可区分具有不同生物学特征和临床结局的 B 细胞慢性淋巴细胞白血病亚群。
Haematologica. 2012 Jan;97(1):56-63. doi: 10.3324/haematol.2011.049874. Epub 2011 Sep 20.
7
Telomere shortening associated with increased genomic complexity in chronic lymphocytic leukemia.端粒缩短与慢性淋巴细胞白血病中基因组复杂性增加相关。
Tumour Biol. 2015 Nov;36(11):8317-24. doi: 10.1007/s13277-015-3556-2. Epub 2015 May 26.
8
Human intron-encoded AluACA RNAs and telomerase RNA share a common element promoting RNA accumulation.人类内含子编码的AluACA RNA与端粒酶RNA共享一个促进RNA积累的共同元件。
RNA Biol. 2016 Dec;13(12):1274-1285. doi: 10.1080/15476286.2016.1239689. Epub 2016 Oct 11.
9
Proteomic analyses reveal new features of the box H/ACA RNP biogenesis.蛋白质组分析揭示了 box H/ACA RNP 生物发生的新特征。
Nucleic Acids Res. 2023 Apr 24;51(7):3357-3374. doi: 10.1093/nar/gkad129.
10
PARP1 Regulates the Biogenesis and Activity of Telomerase Complex Through Modification of H/ACA-Proteins.PARP1通过对H/ACA蛋白的修饰来调节端粒酶复合物的生物合成和活性。
Front Cell Dev Biol. 2021 May 19;9:621134. doi: 10.3389/fcell.2021.621134. eCollection 2021.

引用本文的文献

1
NOP10 predicts poor prognosis and promotes pancreatic cancer progression.NOP10 预测不良预后并促进胰腺癌进展。
BMC Cancer. 2024 Nov 13;24(1):1394. doi: 10.1186/s12885-024-13180-y.
2
Improving risk stratification for 2022 European LeukemiaNet favorable-risk patients with acute myeloid leukemia.改善2022年欧洲白血病网定义的急性髓系白血病低危患者的风险分层。
Innovation (Camb). 2024 Oct 21;5(6):100719. doi: 10.1016/j.xinn.2024.100719. eCollection 2024 Nov 4.
3
May Be a Potential Prognostic Biomarker and Therapeutic Target for Hepatocellular Carcinoma.

本文引用的文献

1
Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS. Clinical staging of chronic lymphocytic leukemia. Blood. 1975;46(2):219-234.赖·KR、萨维茨基·A、克朗凯特·EP、查纳纳·AD、利维·RN、帕斯特纳克·BS。慢性淋巴细胞白血病的临床分期。《血液》。1975年;46(2):219 - 234。
Blood. 2016 Oct 27;128(17):2109. doi: 10.1182/blood-2016-08-737650.
2
A ribosome-related signature in peripheral blood CLL B cells is linked to reduced survival following treatment.外周血慢性淋巴细胞白血病B细胞中一种与核糖体相关的特征与治疗后生存率降低有关。
Cell Death Dis. 2016 Jun 2;7(6):e2249. doi: 10.1038/cddis.2016.148.
3
Differential Expression of Non-Shelterin Genes Associated with High Telomerase Levels and Telomere Shortening in Plasma Cell Disorders.
可能是肝细胞癌的一种潜在预后生物标志物和治疗靶点。
Pharmgenomics Pers Med. 2023 Apr 15;16:337-355. doi: 10.2147/PGPM.S405621. eCollection 2023.
4
Telomere and Telomerase-Associated Proteins in Endometrial Carcinogenesis and Cancer-Associated Survival.端粒和端粒酶相关蛋白在子宫内膜癌发生和与癌症相关的生存中的作用。
Int J Mol Sci. 2022 Jan 6;23(2):626. doi: 10.3390/ijms23020626.
5
Epitranscriptomics in Hematopoiesis and Hematologic Malignancies.造血与血液系统恶性肿瘤中的表观转录组学
Blood Cancer Discov. 2020 Jun 22;1(1):26-31. doi: 10.1158/2643-3249.BCD-20-0032. eCollection 2020 Jul.
6
Non-canonical roles of canonical telomere binding proteins in cancers.非典型端粒结合蛋白在癌症中的作用。
Cell Mol Life Sci. 2021 May;78(9):4235-4257. doi: 10.1007/s00018-021-03783-0. Epub 2021 Feb 18.
7
Aberrant Dyskerin Expression Is Related to Proliferation and Poor Survival in Endometrial Cancer.异常的端粒酶假尿嘧啶合成酶表达与子宫内膜癌的增殖及不良预后相关。
Cancers (Basel). 2021 Jan 13;13(2):273. doi: 10.3390/cancers13020273.
8
Nucleolar protein 10 (NOP10) predicts poor prognosis in invasive breast cancer.核仁蛋白10(NOP10)预示浸润性乳腺癌的预后不良。
Breast Cancer Res Treat. 2021 Feb;185(3):615-627. doi: 10.1007/s10549-020-05999-3. Epub 2020 Nov 8.
9
Genetic interactions of G-quadruplexes in humans.人类中 G-四链体的遗传相互作用。
Elife. 2019 Jul 9;8:e46793. doi: 10.7554/eLife.46793.
10
Telomerase and Telomeres in Endometrial Cancer.子宫内膜癌中的端粒酶与端粒
Front Oncol. 2019 May 17;9:344. doi: 10.3389/fonc.2019.00344. eCollection 2019.
浆细胞疾病中与端粒酶水平升高和端粒缩短相关的非庇护蛋白基因的差异表达
PLoS One. 2015 Sep 14;10(9):e0137972. doi: 10.1371/journal.pone.0137972. eCollection 2015.
4
Differential requirements for H/ACA ribonucleoprotein components in cell proliferation and response to DNA damage.细胞增殖和对DNA损伤反应中H/ACA核糖核蛋白组分的差异需求
Histochem Cell Biol. 2015 Dec;144(6):543-58. doi: 10.1007/s00418-015-1359-6. Epub 2015 Aug 12.
5
Telomere shortening associated with increased genomic complexity in chronic lymphocytic leukemia.端粒缩短与慢性淋巴细胞白血病中基因组复杂性增加相关。
Tumour Biol. 2015 Nov;36(11):8317-24. doi: 10.1007/s13277-015-3556-2. Epub 2015 May 26.
6
Absolute qPCR for measuring telomere length in bone marrow samples of plasma cell disorders.用于测量浆细胞疾病骨髓样本中端粒长度的绝对定量聚合酶链反应。
Mol Biotechnol. 2015 Feb;57(2):155-9. doi: 10.1007/s12033-014-9811-8.
7
Clinical activity of ponatinib in one patient with chronic myeloid leukemia in chronic phase with e19a2 transcript and T315I mutation.波纳替尼在一名慢性期慢性髓性白血病患者中的临床活性,该患者存在e19a2转录本和T315I突变。
Eur J Haematol. 2015 Mar;94(3):270-2. doi: 10.1111/ejh.12358. Epub 2014 May 13.
8
Relevance of telomere/telomerase system impairment in early stage chronic lymphocytic leukemia.端粒/端粒酶系统损伤在早期慢性淋巴细胞白血病中的相关性
Genes Chromosomes Cancer. 2014 Jul;53(7):612-21. doi: 10.1002/gcc.22171. Epub 2014 Apr 4.
9
Human dyskerin: beyond telomeres.人类 dyskerin:超越端粒。
Biol Chem. 2014 Jun;395(6):593-610. doi: 10.1515/hsz-2013-0287.
10
snoRNPs Regulate Telomerase Activity in Neuroblastoma and Are Associated with Poor Prognosis.snoRNPs 调控神经母细胞瘤中端粒酶活性,并与不良预后相关。
Transl Oncol. 2013 Aug 1;6(4):447-57. doi: 10.1593/tlo.13112. Print 2013 Aug.